News Coherus BioSciences Faces FDA Rejection of Udenyca Onbody’s Injectors Shares of Coherus BioSciences dropped on Monday following an announcement that the FDA has issued a complete response letter rejecting a biologics license ... By Artur FernandoSeptember 25, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024